vs
Protalix BioTherapeutics, Inc.（PLX）与Xos, Inc.（XOS）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Xos, Inc.的1.7倍（$9.1M vs $5.2M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -186.8%，领先126.5%），Protalix BioTherapeutics, Inc.同比增速更快（-49.9% vs -54.5%），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -35.7%）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
Xos, Inc.是一家美国制造商，专注于生产商用电动车辆以及移动式电动汽车充电桩。该公司扎根商用车电动化领域，为物流、货运等商业运输场景提供纯电动力解决方案与配套充电设备，助力商用车领域的低碳转型。
PLX vs XOS — 直观对比
营收规模更大
PLX
是对方的1.7倍
$5.2M
营收增速更快
PLX
高出4.6%
-54.5%
净利率更高
PLX
高出126.5%
-186.8%
两年增速更快
PLX
近两年复合增速
-35.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $5.2M |
| 净利润 | $-5.5M | $-9.8M |
| 毛利率 | 49.4% | -50.5% |
| 营业利润率 | -51.1% | -186.6% |
| 净利率 | -60.3% | -186.8% |
| 营收同比 | -49.9% | -54.5% |
| 净利润同比 | -184.8% | 48.6% |
| 每股收益（稀释后） | $-0.06 | $-0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXXOS
| Q4 25 | $9.1M | $5.2M | ||
| Q3 25 | $17.9M | $16.5M | ||
| Q2 25 | $15.7M | $18.4M | ||
| Q1 25 | $10.1M | $5.9M | ||
| Q4 24 | $18.2M | $11.5M | ||
| Q3 24 | $18.0M | $15.8M | ||
| Q2 24 | $13.5M | $15.5M | ||
| Q1 24 | — | $12.6M |
净利润PLXXOS
| Q4 25 | $-5.5M | $-9.8M | ||
| Q3 25 | $2.4M | $2.1M | ||
| Q2 25 | $164.0K | $-7.5M | ||
| Q1 25 | $-3.6M | $-10.2M | ||
| Q4 24 | $6.5M | $-19.0M | ||
| Q3 24 | $3.2M | $-10.5M | ||
| Q2 24 | $-2.2M | $-9.7M | ||
| Q1 24 | — | $-11.0M |
毛利率PLXXOS
| Q4 25 | 49.4% | -50.5% | ||
| Q3 25 | 53.4% | 15.3% | ||
| Q2 25 | 62.5% | 8.8% | ||
| Q1 25 | 19.1% | 20.6% | ||
| Q4 24 | 78.7% | -32.4% | ||
| Q3 24 | 53.4% | 18.1% | ||
| Q2 24 | 29.8% | 13.1% | ||
| Q1 24 | — | 22.1% |
营业利润率PLXXOS
| Q4 25 | -51.1% | -186.6% | ||
| Q3 25 | 11.9% | -42.4% | ||
| Q2 25 | 7.5% | -38.5% | ||
| Q1 25 | -41.0% | -157.7% | ||
| Q4 24 | 39.6% | -127.0% | ||
| Q3 24 | 22.2% | -61.4% | ||
| Q2 24 | -18.0% | -73.2% | ||
| Q1 24 | — | -81.1% |
净利率PLXXOS
| Q4 25 | -60.3% | -186.8% | ||
| Q3 25 | 13.2% | 12.9% | ||
| Q2 25 | 1.0% | -40.8% | ||
| Q1 25 | -35.8% | -173.3% | ||
| Q4 24 | 35.6% | -165.4% | ||
| Q3 24 | 18.0% | -66.6% | ||
| Q2 24 | -16.4% | -62.2% | ||
| Q1 24 | — | -87.1% |
每股收益（稀释后）PLXXOS
| Q4 25 | $-0.06 | $-0.76 | ||
| Q3 25 | $0.03 | $0.22 | ||
| Q2 25 | $0.00 | $-0.91 | ||
| Q1 25 | $-0.05 | $-1.26 | ||
| Q4 24 | $0.10 | $-2.34 | ||
| Q3 24 | $0.03 | $-1.32 | ||
| Q2 24 | $-0.03 | $-1.23 | ||
| Q1 24 | — | $-1.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $14.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $23.3M |
| 总资产 | $82.3M | $60.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLXXOS
| Q4 25 | $14.7M | $14.0M | ||
| Q3 25 | $13.6M | $14.1M | ||
| Q2 25 | $17.9M | $8.8M | ||
| Q1 25 | $19.5M | $4.8M | ||
| Q4 24 | $19.8M | $11.0M | ||
| Q3 24 | $27.4M | $8.4M | ||
| Q2 24 | $23.4M | $19.7M | ||
| Q1 24 | — | $46.2M |
股东权益PLXXOS
| Q4 25 | $48.2M | $23.3M | ||
| Q3 25 | $52.9M | $31.1M | ||
| Q2 25 | $49.9M | $18.3M | ||
| Q1 25 | $45.2M | $24.8M | ||
| Q4 24 | $43.2M | $33.6M | ||
| Q3 24 | $32.4M | $50.8M | ||
| Q2 24 | $28.6M | $59.2M | ||
| Q1 24 | — | $67.8M |
总资产PLXXOS
| Q4 25 | $82.3M | $60.4M | ||
| Q3 25 | $82.3M | $73.8M | ||
| Q2 25 | $78.5M | $80.3M | ||
| Q1 25 | $73.9M | $87.7M | ||
| Q4 24 | $73.4M | $98.3M | ||
| Q3 24 | $61.6M | $120.5M | ||
| Q2 24 | $91.5M | $123.4M | ||
| Q1 24 | — | $135.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $2.4M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | — |
| 自由现金流率自由现金流/营收 | 17.8% | — |
| 资本支出强度资本支出/营收 | 4.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.6M | — |
8季度趋势，按日历期对齐
经营现金流PLXXOS
| Q4 25 | $2.0M | $2.4M | ||
| Q3 25 | $-3.7M | $3.1M | ||
| Q2 25 | $-5.2M | $4.6M | ||
| Q1 25 | $-5.1M | $-4.8M | ||
| Q4 24 | $4.0M | $3.3M | ||
| Q3 24 | $4.1M | $-11.5M | ||
| Q2 24 | $-3.6M | $-26.0M | ||
| Q1 24 | — | $-14.6M |
自由现金流PLXXOS
| Q4 25 | $1.6M | — | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $4.0M | $-11.7M | ||
| Q2 24 | $-3.8M | $-26.1M | ||
| Q1 24 | — | $-14.6M |
自由现金流率PLXXOS
| Q4 25 | 17.8% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -36.2% | — | ||
| Q1 25 | -53.0% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 22.4% | -73.9% | ||
| Q2 24 | -28.1% | -168.1% | ||
| Q1 24 | — | -115.7% |
资本支出强度PLXXOS
| Q4 25 | 4.4% | 0.0% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 2.8% | 0.0% | ||
| Q1 25 | 3.0% | 0.0% | ||
| Q4 24 | 2.3% | 0.0% | ||
| Q3 24 | 0.5% | 0.9% | ||
| Q2 24 | 1.3% | 0.8% | ||
| Q1 24 | — | 0.2% |
现金转化率PLXXOS
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | 1.45× | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
XOS
暂无分部数据
